biote Statistics
Total Valuation
biote has a market cap or net worth of $76.44 million. The enterprise value is $181.32 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 35.55 million shares outstanding. The number of shares has increased by 4.52% in one year.
| Current Share Class | 30.33M |
| Shares Outstanding | 35.55M |
| Shares Change (YoY) | +4.52% |
| Shares Change (QoQ) | +16.77% |
| Owned by Insiders (%) | 13.34% |
| Owned by Institutions (%) | 45.57% |
| Float | 21.14M |
Valuation Ratios
The trailing PE ratio is 5.13 and the forward PE ratio is 10.08.
| PE Ratio | 5.13 |
| Forward PE | 10.08 |
| PS Ratio | 0.42 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.71 |
| P/OCF Ratio | 2.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.82, with an EV/FCF ratio of 6.28.
| EV / Earnings | 11.62 |
| EV / Sales | 0.96 |
| EV / EBITDA | 5.82 |
| EV / EBIT | 6.35 |
| EV / FCF | 6.28 |
Financial Position
The company has a current ratio of 1.29
| Current Ratio | 1.29 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.40 |
| Debt / FCF | 3.75 |
| Interest Coverage | 2.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 16.80% |
| Return on Invested Capital (ROIC) | 49.52% |
| Return on Capital Employed (ROCE) | 46.94% |
| Weighted Average Cost of Capital (WACC) | 9.94% |
| Revenue Per Employee | $843,776 |
| Profits Per Employee | $69,973 |
| Employee Count | 223 |
| Asset Turnover | 1.77 |
| Inventory Turnover | 3.14 |
Taxes
In the past 12 months, biote has paid $5.03 million in taxes.
| Income Tax | 5.03M |
| Effective Tax Rate | 21.45% |
Stock Price Statistics
The stock price has decreased by -46.12% in the last 52 weeks. The beta is 1.71, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.71 |
| 52-Week Price Change | -46.12% |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | 2.54 |
| Relative Strength Index (RSI) | 55.61 |
| Average Volume (20 Days) | 174,927 |
Short Selling Information
The latest short interest is 1.48 million, so 4.17% of the outstanding shares have been sold short.
| Short Interest | 1.48M |
| Short Previous Month | 1.69M |
| Short % of Shares Out | 4.17% |
| Short % of Float | 7.01% |
| Short Ratio (days to cover) | 4.81 |
Income Statement
In the last 12 months, biote had revenue of $188.16 million and earned $15.60 million in profits. Earnings per share was $0.43.
| Revenue | 188.16M |
| Gross Profit | 131.93M |
| Operating Income | 28.54M |
| Pretax Income | 23.47M |
| Net Income | 15.60M |
| EBITDA | 31.14M |
| EBIT | 28.54M |
| Earnings Per Share (EPS) | $0.43 |
Full Income StatementBalance Sheet
The company has $5.32 million in cash and $108.42 million in debt, with a net cash position of -$103.10 million or -$2.90 per share.
| Cash & Cash Equivalents | 5.32M |
| Total Debt | 108.42M |
| Net Cash | -103.10M |
| Net Cash Per Share | -$2.90 |
| Equity (Book Value) | -47.96M |
| Book Value Per Share | -1.83 |
| Working Capital | 8.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $32.63 million and capital expenditures -$3.75 million, giving a free cash flow of $28.88 million.
| Operating Cash Flow | 32.63M |
| Capital Expenditures | -3.75M |
| Depreciation & Amortization | 2.59M |
| Net Borrowing | -57.33M |
| Free Cash Flow | 28.88M |
| FCF Per Share | $0.81 |
Full Cash Flow StatementMargins
Gross margin is 70.12%, with operating and profit margins of 15.17% and 8.29%.
| Gross Margin | 70.12% |
| Operating Margin | 15.17% |
| Pretax Margin | 12.47% |
| Profit Margin | 8.29% |
| EBITDA Margin | 16.55% |
| EBIT Margin | 15.17% |
| FCF Margin | 15.35% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.52% |
| Shareholder Yield | -4.52% |
| Earnings Yield | 19.95% |
| FCF Yield | 36.93% |
Analyst Forecast
The average price target for biote is $2.83, which is 31.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.83 |
| Price Target Difference | 31.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 5.56% |
| EPS Growth Forecast (5Y) | -0.71% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 6 |
